Alembic Pharmaceuticals’s joint venture, Aleor Dermaceuticals Limited, has received US Food and Drug Administration (USFDA) Tentative Approval for Diclofenac Sodium Topical Solution USP, 2% w/w.
source https://www.pharmatutor.org/pharma-news/2019/alembic-pharmaceuticals-joint-venture-received-usfda-approval-for-diclofenac-sodium-topical-solution
No comments:
Post a Comment